Filter
661
Text search:
pooled
testing
Featured
73
158
Language
Document type
312
137
109
37
31
16
8
6
2
1
Countries / Regions
33
27
22
18
18
16
14
12
12
12
11
11
11
9
9
9
8
7
7
7
6
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
230
92
38
28
19
17
1
Toolboxes
81
70
69
35
30
20
13
13
13
12
10
10
9
9
8
8
7
7
4
3
2
2
1
1
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
Lancet Planet Health 2017 Published Online November 6, 2017 http://dx.doi.org/10.1016/S2542-5196(17)30141-9
Lessons from the STEP-TB Project.
Accessed November 2017.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Scientific advice
Prevention and control of communicable diseases in prison settings.
DHS Analytical Studies No. 39
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf
...